Proactive treatment appears to decrease serum immunoglobulin-E levels in patients with severe atopic dermatitis.
Fukuie
T
T
Nomura
I
I
Horimukai
K
K
Manki
A
A
Masuko
I
I
Futamura
M
M
Narita
M
M
Ohzeki
T
T
Matsumoto
K
K
Saito
H
H
Ohya
Y
Y
D000287:Administration, Topical; D000305:Adrenal Cortex Hormones / Q000008:administration & dosage / Q000627:therapeutic use*; D001623:Betamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D002908:Chronic Disease; D003876:Dermatitis, Atopic / Q000097:blood* / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000627:therapeutic use*; D007073:Immunoglobulin E / Q000097:blood*; D007223:Infant; D008297:Male; D012189:Retrospective Studies
D000305:Adrenal Cortex Hormones; D007073:Immunoglobulin E; D001623:Betamethasone; D006854:Hydrocortisone